Holistic Planning’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$421K Buy
1,674
+51
+3% +$11K 0.07% 231
2026
Q1
$353K Sell
1,623
-79
-5% -$17.5K 0.07% 220
2025
Q4
$389K Buy
1,702
+367
+27% +$83.6K 0.08% 192
2025
Q3
$309K Sell
1,335
-38
-3% -$7.74K 0.08% 181
2025
Q2
$255K Sell
1,373
-17
-1% -$3.16K 0.07% 189
2025
Q1
$291K Buy
1,390
+36
+3% +$7K 0.1% 145
2024
Q4
$241K Buy
1,354
+293
+28% +$53.9K 0.09% 152
2024
Q3
$210K Buy
+1,061
New +$198K 0.09% 150

Other funds holding ABBV

Holistic Planning's ABBV Position: Q2 2026 in Review

Holistic Planning increased its AbbVie (ABBV) stake by 3.1% in Q2 2026, buying an estimated $11K and bringing the position to 1,674 shares worth $421K. The position accounts for 0.07% of the portfolio, ranked #231.

Holistic Planning first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Holistic Planning held 1,674 shares of AbbVie worth $421K as of Q2 2026.
  • Holistic Planning bought 51 AbbVie shares in Q2 2026, an estimated $11K.
  • AbbVie made up 0.07% of Holistic Planning's portfolio in Q2 2026, its #231 holding.
  • Holistic Planning first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Holistic Planning's 13F filing for Q2 2026, filed 10 Aug 2026.